Media & Press Updates

Find out BCAL's latest updates and activity

A124B8FD-B90E-4813-8E57-AE419413959B.jpeg

Our new CEO John Hurrell speaking to Yolanda Redrup at The Australian Financial Review: “Looking at the technology and how it’s been validated made me interested. I’ve taken this on because I think I can do something of significance here.”

17 March 2022

View article

download.jfif

BCAL Diagnostics Lists on ASX

BCAL Diagnostics lists on ASX after raising $10 million in IPO. Download ASX Announcement.

Captureja.JPG

A new way to detect cancer cells is coming to market - Aus Biz

BCAL Diagnostics has closed off a $4M pre-IPO capital raise to fund trials of its breast cancer blood test. Chairperson Jayne Shaw says it could revolutionise how we detect cancer cells. Jayne Shaw BCAL's Executive Chair interviewed by Aus Biz. View video. 

Captureaa.JPG

Breast cancer blood test biotech scores fresh funds - Financial Review

Early-stage biotech BCAL Diagnostics has closed a $4 million pre-IPO capital raise led by Citadel Group's Mark McConnell, which will fund clinical trials for a breakthrough low-cost breast cancer detection blood test.

Founded by healthcare industry veteran and former Vision Group executive Jayne Shaw with former NSW health minister Ron Phillips, the funding round comes after more than a decade of blood, sweat and tears, as well as personal investment, which has led to the commencement of a phase-one... read full article.

Captureaaaa.JPG

Year One In Review - The Sydney Knowledge Hub

Amani Batarseh from BCAL Diagnostics talks about why her work is important and how the Sydney Knowledge Hub is helping BCAL achieve their aims. Download article.

Sydney uni Logo.JPG

Sydney Knowledge Hub

BCAL Diagnostics partners with Sydney Knowledge Hub And Sydney Mass Spectrometry

HOverH2.JPG

BCAL Diagnostics Wins "Win The Future" Contest For International Entrepreneurs in Oceania Programme

October 2019

download.jpg

BCAL Diagnostics Presents at Heads Over Heels Melbourne

June 2019

1627883012087.jfif

BCAL Diagnostics -NSW Government  Industry Sectors Announcements

BCAL Diagnostics is a wholly Australian-owned biotechnology company based at the National Innovation Centre at Eveleigh. Since its establishment in 2010, BCAL Diagnostics has been striving to revolutionise early detection and screening for breast cancer for women worldwide...Read article 

imagea.JPG

Interview with La Roche University 

Amani Batarseh is a Senior Research Scientist Lipidomics and Mass Spectrometry for BCAL Diagnostics... Read article 

Jayne.jpg

BCAL - The Revolutionary Blood Test for Cancer

2016